Syngene International Ltd

SYNGENE

Company Profile

  • Business description

    Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

  • Contact

    Jigani Link Road, Biocon SEZ, Biocon Park
    Plot No. 2 and 3, IV Phase
    Bommasandra Industrial Area
    BangaloreKA560 099
    IND

    T: +91 8068918000

    https://www.syngeneintl.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 March 2027

    Employees

    6,533

Stocks News & Analysis

stocks

Undervalued ASX share retains wide moat rating despite regulatory pressures

Proposed price regulation impacts our fair value.
stocks

Our top ASX picks in every sector

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks

Tesla: Shares fall as deliveries come in below consensus

Long-term growth less reliant on auto sales.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,165.702.000.02%
CAC 408,297.27388.534.91%
DAX 4024,086.191,164.605.08%
Dow JONES (US)47,916.371,331.912.86%
FTSE 10010,658.69309.902.99%
HKSE25,893.02776.493.09%
NASDAQ22,643.98626.132.84%
Nikkei 22556,308.422,878.865.39%
NZX 50 Index13,253.94184.281.41%
S&P 5006,774.58157.732.38%
S&P/ASX 2008,951.8021.00-0.23%
SSE Composite Index3,995.00104.832.69%

Market Movers